FDA Inspection 740844 — AmbioPharm, Inc

AmbioPharm, Inc — FEI 3006446551

The FDA completed an inspection of AmbioPharm, Inc on August 16, 2011 in Beech Island, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 16, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Beech Island, SC (United States)